Virax Biolabs Group (NASDAQ: VRAX) is owned by 0.81% institutional shareholders, 0.00% Virax Biolabs Group insiders, and 99.19% retail investors. Citadel Advisors LLC is the largest individual Virax Biolabs Group shareholder, owning 30,155.00 shares representing 0.69% of the company. Citadel Advisors LLC's Virax Biolabs Group shares are currently valued at $17.97k.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.